Kimberly-Clark (Nasdaq: KMB) in its pending $48.7 billion acquisition of Kenvue (NYSE: KVUE), a provider of consumer health products
Berkshire Hathaway (NYSE: BRK) in its pending $9.7 billion acquisition of OxyChem, a provider of commodity chemicals, from Occidental Petroleum Corp. (NYSE: OXY)
KKR-backed Headlands Research, a provider of a network of clinical trial sites, in its sale to THL
DNOW (NYSE: DNOW) in its $1.5 billion acquisition of MRC Global (NYSE: MRC), a provider of pipe, valves, fittings and other infrastructure products and services.
